364 related articles for article (PubMed ID: 25936382)
1. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
[TBL] [Abstract][Full Text] [Related]
2. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
3. Iptakalim ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Li J; Long C; Cui W; Wang H
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):60-9. PubMed ID: 22947433
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
5. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
6. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery.
Wu JR; Kao LP; Wu BN; Dai ZK; Wang YY; Chai CY; Chen IJ
Kaohsiung J Med Sci; 2015 May; 31(5):241-54. PubMed ID: 25910559
[TBL] [Abstract][Full Text] [Related]
7. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
8. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels.
Zhu HL; Luo WQ; Wang H
Neuroscience; 2008 Dec; 157(4):884-94. PubMed ID: 18951957
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib alleviates experimental pulmonary arterial hypertension.
Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
[TBL] [Abstract][Full Text] [Related]
11. Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
Bi LQ; Zhu R; Kong H; Wu SL; Li N; Zuo XR; Zhou SM; Kou JP; Yu BY; Wang H; Xie WP
Int Immunopharmacol; 2013 May; 16(1):7-16. PubMed ID: 23538027
[TBL] [Abstract][Full Text] [Related]
12. Effects of iptakalim hydrochloride, a novel KATP channel opener, on pulmonary vascular remodeling in hypoxic rats.
Xie W; Wang H; Wang H; Hu G
Life Sci; 2004 Sep; 75(17):2065-76. PubMed ID: 15312751
[TBL] [Abstract][Full Text] [Related]
13. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
Pan Z; Huang J; Cui W; Long C; Zhang Y; Wang H
J Cardiovasc Pharmacol; 2010 Sep; 56(3):215-28. PubMed ID: 20410832
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
Luan Y; Chao S; Ju ZY; Wang J; Xue X; Qi TG; Cheng GH; Kong F
Int Immunopharmacol; 2015 May; 26(1):188-93. PubMed ID: 25601497
[TBL] [Abstract][Full Text] [Related]
15. The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.
Wang Y; Zeng FH; Long CL; Pan ZY; Cui WY; Wang RH; Liu GS; Wang H
Acta Pharmacol Sin; 2011 Dec; 32(12):1466-74. PubMed ID: 22056616
[TBL] [Abstract][Full Text] [Related]
16. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Tan JX; Huang XL; Wang B; Fang X; Huang DN
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic pulmonary hypertension and novel ATP-sensitive potassium channel opener: the new hope on the horizon.
Jin Y; Xie WP; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):510-23. PubMed ID: 23581180
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension.
Li B; Yan J; Shen Y; Liu Y; Ma Z
Mol Med Rep; 2014 Oct; 10(4):2144-52. PubMed ID: 25110234
[TBL] [Abstract][Full Text] [Related]
19. Iptakalim induces mitochondria-dependent apoptosis in hypoxic rat pulmonary arterial smooth muscle cells.
Xu Q; Wu X; Li Y; Kong H; Jin Y; Xie W; Wang H
Biomed Pharmacother; 2016 Dec; 84():773-779. PubMed ID: 27718461
[TBL] [Abstract][Full Text] [Related]
20. [The selective dilatation effects of iptakalim on pulmonary arterioles in hypoxic pulmonary hypertensive rat].
Huang JH; Han WZ; Zhang YF; Duan RF; Deng HH; Guo YH; Liu W; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Jul; 29(4):333-6. PubMed ID: 24175556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
